Article 5.3 of the WHO Framework Convention on Tobacco Control requires governments to protect public health policy from the commercial and vested interests of the tobacco industry. It is one of the core reasons a database like Tobacco Nexus exists.
Data: WHO FCTC Convention text, WHO FCTC parties page and Article 5.3 implementation guidelines. Party count checked against WHO FCTC Secretariat materials, accessed June 2026.
Article 5.3 is based on a simple premise: there is a fundamental and irreconcilable conflict between the tobacco industry’s interests and public health policy. The implementation guidelines ask governments to limit interactions with the tobacco industry, make necessary interactions transparent, reject partnerships, avoid conflicts of interest and protect policymaking from commercial influence.
The principle does not mean governments can never speak to tobacco companies. It means interactions should be necessary, accountable and transparent rather than routine, privileged, undisclosed or insufficiently documented.
Article 5.3 turns network mapping into a public-interest task. A documented link to a tobacco company is not proof of control or misconduct, but it is relevant context. If a lobbyist, research project, trade association, event, think tank or consumer group has such a link, policymakers and journalists should know it before treating the actor as independent.
Database relevance: Tobacco Nexus does not replace Article 5.3 due diligence. It helps identify the relationships that should trigger further verification, disclosure checks and source review.
When assessing an actor in tobacco policy, Article 5.3 points to practical questions: who funds it, who governs it, who benefits from its position, whether it has disclosed tobacco-company links, and whether its work appears in legislation, taxation, product regulation or treaty negotiations.
This is especially relevant for newer nicotine products. A position on vaping, heated tobacco or nicotine pouches is not automatically industry-driven. The issue is whether the actor presenting that position is materially connected to a tobacco company or tobacco-funded structure.
This page was drafted from public sources. Company figures and product information should be checked against the linked annual reports, regulatory filings and official pages before citation, because financial data and product portfolios change over time.